PDL BIOPHARMA INC

CUSIP: 69329Y104 Class: COM

FULLER & THALER ASSET MANAGEMENT, INC.'s Holding History (CIK: 0001082327)

Note: Option positions (PUT/CALL) are excluded.

Q3 2020
Shares 1,129,470 Value ($000) $3,558 Avg Close Range
Q2 2020
Shares 1,186,100 Value ($000) $3,452 Avg Close Range
Q1 2020
Shares 1,216,690 Value ($000) $3,431 Avg Close Range
Q4 2019
Shares 1,109,145 Value ($000) $3,599 Avg Close Range
Q3 2019
Shares 1,105,970 Value ($000) $2,389 Avg Close Range
Q2 2019
Shares 1,243,125 Value ($000) $3,903 Avg Close Range
Q1 2019
Shares 1,250,040 Value ($000) $4,650 Avg Close Range
Q4 2018
Shares 1,231,730 Value ($000) $3,572 Avg Close Range
Q3 2018
Shares 1,211,150 Value ($000) $3,185 Avg Close Range
Q2 2018
Shares 1,211,150 Value ($000) $2,834 Avg Close Range
Q1 2018
Shares 1,211,300 Value ($000) $3,561 Avg Close Range
Q4 2017
Shares 1,297,300 Value ($000) $3,555 Avg Close Range
Q3 2017
Shares 1,701,500 Value ($000) $5,768 Avg Close Range
Q2 2017
Shares 1,709,500 Value ($000) $4,222 Avg Close Range
Q1 2017
Shares 704,800 Value ($000) $1,600 Avg Close Range